Progress in the development of therapeutic antibodies targeting prion proteins and β-amyloid peptides

Science China Life Sciences

Volumn 53, Issue 8, 2010, Pages 959-963

  He, JinSheng ^a   Zhang, Ying ^a   Hong, Tao ^a,b  

^a BEIJING JIAOTONG UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Alzheimer's disease; antibody; conformation; immunotherapy; prion

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY;

HUMAN; IMMUNOLOGY; PRION; REVIEW;

AMYLOID BETA-PEPTIDES; ANTIBODIES; HUMANS; PRIONS;

EID: 77956453910     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-4043-z     Document Type: Review

References (37)

1. Ulrih N P, Skrt M, Veranic P, et al. Oligomeric forms of peptide fragment PrP (214-226) in solution are preferentially recognized by PrP (Sc)-specific antibody. Biochem Biophys Res Commun, 2006, 344: 1320-1326.
2. Skrlj N, Serbec V C, Dolinar M. Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against Peptide P1 of the human prion protein. Appl Biochem Biotechnol, 2010, 160: 1808-1821.
3. Curin Serbec V, Bresjanac M, Popovic M, et al. Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue. J Biol Chem, 2004, 279: 3694-3698.
4. Horiuchi M, Karino A, Furuoka H, et al. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity. Virology, 2009, 394: 200-207.
5. Lambert M P, Velasco P T, Chang L, et al. Monoclonal antibodies that target pathological assemblies of Aβ. J Neurochem, 2007, 100: 23-35.
6. Lee E B, Leng L Z, Zhang B, et al. Targeting amyloid-beta peptide (Aβ) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Aβ precursor protein (APP) transgenic mice. J Biol Chem, 2006, 281: 4292-4299.
7. Wang X P, Zhang J H, Wang Y J, et al. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers. FEBS Lett, 2009, 583: 579-584.
8. Colja Venturini A, Bresjanac M, Vranac T, et al. Anti-idiotypic antibodies: a new approach in prion research. BMC Immunol, 2009, 10: 16.
9. Hanoux V, Wijkhuisen A, Alexandrenne C, et al. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein. Mol Immunol, 2009, 46: 1076-1083.
10. Paramithiotis E, Pinard M, Lawton T, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat Med, 2003, 9: 893-899.
11. Novitskaya V, Makarava N, Bellon A, et al. Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay. J Biol Chem, 2006, 281: 15536-15545.
12. C degra dation. J Neurochem, 2004, 89: 454-463.
13. Kim C L, Umetani A, Matsui T, et al. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology, 2004, 320: 40-51.
14. Sc replication in infected cells. J Biol Chem, 2005, 280: 11247-11258.
15. Miyamoto K, Nakamura N, Aosasa M, et al. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein. Biochem Biophys Res Commun, 2005, 335: 197-204.
16. Sc accumulation. J Biol Chem, 2005, 280: 685-694.
17. Vetrugno V, Cardinale A, Filesi I, et al. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity. Biochem Biophys Res Commun, 2005, 338: 1791-1797.
18. Sc binding antibodies are potent inhibitors of prion replication in cell lines. J Biol Chem, 2004, 279: 39671-39676.
19. Pankiewicz J, Prelli F, Sy M S, et al. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies. Eur J Neurosci, 2006, 23: 2635-2647.
20. Sc)-specific epitope defined by a monoclonal antibody. Nature, 1997, 390: 74-77.
21. Bard F, Barbour R, Cannon C, et al. Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci USA, 2003, 100: 2023-2028.
22. Thakker D R, Weatherspoon M R, Harrison J, et al. Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proc Natl Acad Sci USA, 2009, 106: 4501-4506.
23. Movsesyan N, Mkrtichyan M, Petrushina I, et al. DNA epitope vaccine containing complement component C3d enhances anti-amyloidbeta antibody production and polarizes the immune response towards a Th2 phenotype. J Neuroimmunol, 2008, 205: 57-63.
24. Shimizu Y, Kaku-Ushiki Y, Iwamaru Y, et al. A novel anti-prion protein monoclonal antibody and its single-chain fragment variable derivative with ability to inhibit abnormal prion protein accumulation in cultured cells. Microbiol Immunol, 2010, 54: 112-121.
25. Skrlj N, Serbec V C, Dolinar M. Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein. Appl Biochem Biotechnol, 2010, 160: 1808-1821.
26. Donofrio G, Heppner F L, Polymenidou M, et al. Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. J Virol, 2005, 79: 8330-8338.
27. Flego M, Ascione A, Zamboni S, et al. Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells. BMC Biotechnol, 2007, 7: 38.
28. Meli G, Visintin M, Cannistraci I, et al. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers. J Mol Biol, 2009, 387: 584-606.
29. Robert R, Dolezal O, Waddington L, et al. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers. Protein Eng Des Sel, 2009, 22: 199-.
30. Zameer A, Kasturirangan S, Emadi S, et al. Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells. J Mol Biol, 2008, 384: 917-28.
31. Robert R, Streltsov V A, Newman J, et al. Germline humanization of a murine Abeta antibody and crystal structure of the humanized recombinant Fab fragment. Protein Sci, 2010, 19: 299-308.
32. Medecigo M, Manoutcharian K, Vasilevko V, et al. Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries. J Neuroimmunol, 2010, 223: 104-114.
33. Zhao L, Hou X, Ji R, et al. Establishment of bovine prion peptide-based monoclonal antibodies for identifying bovine prion. Sci China Ser C-Life Sci, 2009, 52: 754-760.
34. Zhang Y, Wang X, He J S, et al. Preparation and characterization of a monoclonal antibody with high affinity for soluble Aβ oligomers. Hybridoma, 2009, 28: 349-354.
35. Bao F X, He J S, Cao G F, et al. Isolation and identification of a human single chain Fv antibody against amyloid-beta 1-42 soluble oligomers from a human phage display library (in Chinese). Chin J Biotech, 2009, 25: 1195-1203.
36. The first recombinant humanized monoclonal antibody drug in China. (in Chinese). Chin Med Biotechol, 2008, 3: 384.
37. Zhang Y, He J S, Hong T. Advances and applications of recombinant antibody drugs (in Chinese). China Biotechnol, 2009, 29: 102-106.